Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Linker

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Journal of Neuro-Oncology|July 21, 2025
Dietary habits in relation to outcome and therapy-related toxicity in patients with glioblastoma - a retrospective cohort studyTareq M Haedenkamp, Linda Götz, Tananeh Ansafi, et al.
BMC Palliative Care|January 16, 2026
Palliative care interventions and outcome in patients with glioblastoma - a retrospective, single-center studyLisa-Marie Lind, Anna Fischl, Elisabeth Goettl, et al.
Neuro-Oncology Practice|September 18, 2023
Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective studyAnna Fischl, Michael Gerken, Philipp Roos, et al.
Cancers|November 20, 2020
Non-Invasive Prediction of <i>IDH</i> Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo <sup>1</sup>H-Magnetic Resonance Spectroscopy and Machine LearningElisabeth Bumes, Fro-Philip Wirtz, Claudia Fellner, et al.
Cancers|June 10, 2022
Validation Study for Non-Invasive Prediction of <i>IDH</i> Mutation Status in Patients with Glioma Using In Vivo <sup>1</sup>H-Magnetic Resonance Spectroscopy and Machine LearningElisabeth Bumes, Claudia Fellner, Franz A Fellner, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their CaregiversAnna Fischl, Michael Gerken, Patricia Lindberg-Scharf, et al.
Nature Communications|April 26, 2020
Ethanol consumption inhibits T<sub>FH</sub> cell responses and the development of autoimmune arthritisVugar Azizov, Katharina Dietel, Franziska Steffen, et al.
Journal of Neurology|November 4, 2023
Weaning and extubation failure in myasthenic crisis: a multicenter analysisBernhard Neumann, Klemens Angstwurm, Christian Dohmen, et al.
Der Nervenarzt|July 13, 2019
[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]Stefan Bittner, Sinah Engel, Christoph Lange, et al.
Ebiomedicine|May 28, 2020
Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort studyStefan Bittner, Falk Steffen, Timo Uphaus, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Neuro-Oncology|July 21, 2025
Dietary habits in relation to outcome and therapy-related toxicity in patients with glioblastoma - a retrospective cohort studyTareq M Haedenkamp, Linda Götz, Tananeh Ansafi, et al.
BMC Palliative Care|January 16, 2026
Palliative care interventions and outcome in patients with glioblastoma - a retrospective, single-center studyLisa-Marie Lind, Anna Fischl, Elisabeth Goettl, et al.
Neuro-Oncology Practice|September 18, 2023
Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective studyAnna Fischl, Michael Gerken, Philipp Roos, et al.
Cancers|November 20, 2020
Non-Invasive Prediction of <i>IDH</i> Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo <sup>1</sup>H-Magnetic Resonance Spectroscopy and Machine LearningElisabeth Bumes, Fro-Philip Wirtz, Claudia Fellner, et al.
Cancers|June 10, 2022
Validation Study for Non-Invasive Prediction of <i>IDH</i> Mutation Status in Patients with Glioma Using In Vivo <sup>1</sup>H-Magnetic Resonance Spectroscopy and Machine LearningElisabeth Bumes, Claudia Fellner, Franz A Fellner, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their CaregiversAnna Fischl, Michael Gerken, Patricia Lindberg-Scharf, et al.
Nature Communications|April 26, 2020
Ethanol consumption inhibits T<sub>FH</sub> cell responses and the development of autoimmune arthritisVugar Azizov, Katharina Dietel, Franziska Steffen, et al.
Journal of Neurology|November 4, 2023
Weaning and extubation failure in myasthenic crisis: a multicenter analysisBernhard Neumann, Klemens Angstwurm, Christian Dohmen, et al.
Der Nervenarzt|July 13, 2019
[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]Stefan Bittner, Sinah Engel, Christoph Lange, et al.
Ebiomedicine|May 28, 2020
Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort studyStefan Bittner, Falk Steffen, Timo Uphaus, et al.
Pageof 5